EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder

Brandon Weiss, Leor Roseman, Bruna Giribaldi, David J. Nutt, Robin L. Carhart-Harris, David Erritzoe

International Journal of Mental Health and Addiction · 2024-04 · 22 (2) · 806-841

DOI: 10.1007/s11469-024-01253-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Mental Health and Addiction, online erschienen am 07.03.2024. Verfasst von Brandon Weiss und 5 weiteren Autor:innen. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanisms by which Psilocybin Therapy (PT) improves depression remain an important object of study, with scientists actively exploring acute psychological experiences and neurobiological processes as candidates. In a phase 2, double-blind, randomized, active comparator controlled trial involving patients with moderate-to-severe major depressive disorder, we investigated whether acute psychological experiences could meaningfully account for the unique efficacy of PT versus Escitalopram Treatment over a core 6-week trial period. An exploratory-factor-analysis-derived single-factor of depression was used as the outcome. Among a comprehensive set of acute experiences related to psilocybin, so-called “mystical experience” and “ego dissolution” were unique in mediating the effect of treatment condition on depressive response with high specificity. Higher reported levels of mystical experience, emotional breakthrough, and intense responses to music-listening were furthermore associated with greater antidepressant response. These results provide qualified support for the causal mechanistic role of acute psychological experiences in the treatment of depression via PT.

Zitieren

APA

Weiss, B., Roseman, L., Giribaldi, B., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2024). Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder. International Journal of Mental Health and Addiction, 22(2), 806-841. https://doi.org/10.1007/s11469-024-01253-9

Vancouver

Weiss B, Roseman L, Giribaldi B, Nutt DJ, Carhart-Harris RL, Erritzoe D. Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder. International Journal of Mental Health and Addiction. 2024;22(2):806-841. doi:10.1007/s11469-024-01253-9

BibTeX
@article{Weiss2024,
  author = {Weiss, Brandon and Roseman, Leor and Giribaldi, Bruna and Nutt, David J. and Carhart-Harris, Robin L. and Erritzoe, David},
  title = {Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder},
  journal = {International Journal of Mental Health and Addiction},
  year = {2024},
  volume = {22},
  number = {2},
  pages = {806--841},
  doi = {10.1007/s11469-024-01253-9}
}
Kostenlos starten →